<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="66966">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01682239</url>
  </required_header>
  <id_info>
    <org_study_id>EC 023/2012</org_study_id>
    <nct_id>NCT01682239</nct_id>
  </id_info>
  <brief_title>Effects of Right Ventricular Pacemaker Lead Position Assessed by MRI</brief_title>
  <official_title>Effects of Different Right Ventricular Lead Positioning on Cardiac Contraction Measured by Cardiac MRI: a Pilot Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <authority>Austria: Agency for Health and Food Safety</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chronic right ventricular apical pacing has been associated with negative hemodynamic
      effects. Clinical outcome of right ventricular pacing can be influenced by multiple factors.
       An important factor seems to be optimal lead positioning. Data regarding left ventricular
      function impaired by lead positioning is insufficient. The aim of the present study
      therefore is to compare right ventricular apical pacing (RVAP) with right ventricular septal
      pacing (RVSP). Outcome measurements are echocardiographic features, magnetic resonance
      imaging and clinical outcome.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Anticipated">August 2015</completion_date>
  <primary_completion_date type="Anticipated">August 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>Ejection Fraction</measure>
    <time_frame>6 month</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>As primary endpoint the difference of ventricular function in both groups will be taken. Therefore the Ejection Fraction is measured in cardiac MRI and Echocardiography. There may be a different development of contraction, whether the lead is placed in the ventricular apex or the ventricular septum.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Late Complication From Cardiac Pacemaker Implantation</condition>
  <arm_group>
    <arm_group_label>RVAP lead</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pacemaker lead implantation:
Pacemaker leads will be placed in specific predefined RA and RV sites according to randomization. In this arm pacemaker leads will be placed in the RV apex. The successful lead positioning at its target location will be verified by surface ECG and by fluoroscopy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RVSP arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pacemaker lead implantation:
Pacemaker leads will be placed in specific predefined RA and RV sites according to randomization. In this arm pacemaker leads will be placed in the RV septum. The successful lead positioning at its target location will be verified by surface ECG and by fluoroscopy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>RVAP</intervention_name>
    <description>In this arm pacemaker leads will be placed in the RV apex.</description>
    <arm_group_label>RVAP lead</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>RVSP</intervention_name>
    <description>In this arm pacemaker leads will be placed in the RV septum.</description>
    <arm_group_label>RVSP arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  patients with dysrhythmia requiring dual-chamber pacemaker implantation

          -  planed MRI-pacemaker implantation (Accent MRI System,St. Jude Medical)

          -  age between 18-90 years

          -  no absolute pacemaker dependence

          -  no present heart failure or any significant coronary heart disease (exclusion by
             anamnesis and echocardiography - LVH &lt;15mm, LV EF&gt;50%)

          -  no previous myocardial infarction or significant coronary artery disease

          -  life expectancy &gt; 1 year

          -  patients willing to participate in follow-up

        Exclusion criteria:

          -  Contraindications for MRI (Brain aneurysm clips, artificial heart valves, artificial
             joints, vascular stents)

          -  Any contraindication for surgery

          -  Absolute pacemaker dependence

          -  Claustrophobia

          -  GFR&lt;30ml/min/1,73m2

          -  Allergy to contrast agent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alfred Kocher, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Cardiac Surgery</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Cardiac Surgery, MUV</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <reference>
    <citation>Beinart R, Nazarian S. MRI-Conditional Cardiac Implantable Electronic Devices: What's New and What Can We Expect in the Future? Curr Treat Options Cardiovasc Med. 2012 Oct;14(5):558-64. doi: 10.1007/s11936-012-0197-2.</citation>
    <PMID>22851216</PMID>
  </reference>
  <reference>
    <citation>Cano O, Osca J, Sancho-Tello MJ, Sánchez JM, Ortiz V, Castro JE, Salvador A, Olagüe J. Comparison of effectiveness of right ventricular septal pacing versus right ventricular apical pacing. Am J Cardiol. 2010 May 15;105(10):1426-32. doi: 10.1016/j.amjcard.2010.01.004. Epub 2010 Mar 30.</citation>
    <PMID>20451689</PMID>
  </reference>
  <reference>
    <citation>Inoue K, Okayama H, Nishimura K, Saito M, Yoshii T, Hiasa G, Sumimoto T, Inaba S, Suzuki J, Ogimoto A, Funada J, Higaki J. Right ventricular septal pacing preserves global left ventricular longitudinal function in comparison with apical pacing: analysis of speckle tracking echocardiography. Circ J. 2011;75(7):1609-15. Epub 2011 May 20.</citation>
    <PMID>21597204</PMID>
  </reference>
  <verification_date>September 2012</verification_date>
  <lastchanged_date>September 7, 2012</lastchanged_date>
  <firstreceived_date>September 6, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Alfred A Kocher, MD</investigator_full_name>
    <investigator_title>MD., Prof.</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
